BioSig Technologies, Inc.
Stock Promoter Performance
Last 1 Stock Promotions By "Lion Stock Alerts"
|PURE||PURE Bioscience||May 11, 2022||0.166||-7%|
BSGM Promotional Newsletter
The following is a newsletter released by "Lion Stock Alerts" promoting BioSig Technologies, Inc.
Don't Want Anymore Emails
BSGM, our newest alert, opened Wednesday at 0.90 and rallied to a high of 1.05, so far experiencing upside of over 16%.
BSGM closed near the high of the day at 1.00, up 11% from Wednesdays open.
As a reminder, yesterday the company announced
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
Here are the highlights from this press release
To date, Company's FDA 510k cleared PURE EPTM system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the United States
The Company adds new executives to accelerate sustained commercial momentum developing a national installed base of the PURE EP systems
Furthermore, Recent Company highlights include
The growth of its PURE EPTM System from its first-in-human surgical procedures in 2019 to completing over 2,200 patient cases with 75 physicians at 17 hospitals across the United States.
BioSig strengthened its management with a new commercialization team led by industry veteran Gray Fleming, Chief Commercial Officer, who spent 18 years with St. Jude Medical.
The rollout of a two-phase approach for purchase, lease, or rental options for PURE EP and a new go-to-market strategy for commercialization.
Launch of its new NOVA-5 software at the Heart Rhythm Society Convention on April 29, 2022. NOVA-5 offers greater customization and smarter workflows with the aim of further driving clinical adoption.
Recapped the successful completion of its first blinded clinical trial in 2021 and published those results in a leading peer-reviewed journal. Titled Evaluation of a novel cardiac signal processing system for electrophysiology procedures The PURE EP 2.0 study, the study was conducted at three leading medical centers across the United States St. David's Medical Center TCAI, Mayo Clinic, and Massachusetts General Hospital.
A snapshot into Biosig's financing included no debt and positioning in a global electrophysiology device market which, according to Grand View Research, could reach $12.2 billion by 2026 and expand at a growth rate of approximately 12%.
Here are some of the companys comments from this press release
We have made great strides on multiple fronts and felt it was an important time to communicate to our shareholders the strength of our business and the initiatives we are executing that have served as the foundation for our growth trajectory, said Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. We strongly believe in the value of our technology and are now supported with both peer-reviewed clinical data and third-party economic data, proving the value of what we have built. We are eager to continue working on our new commercialization strategy, seeing the impact of our new NOVA-5 software has, and all our initiatives we are undertaking to drive shareholder value and expand PURE EP.
We are continuing to monitor this opportunity.
Sources , , , , , , , , , , , , ,
Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.
You should read and understand this disclaimer in its entirety before joining the website or emailblog list of LionStockAlerts.com the Publisher. The information collectively the Advertisement disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, andor losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply.
The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.gov the Financial Industry Regulatory Authority the FINRA at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.
The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial andor legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.
Owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 42922 for the distribution of this advertisement about BSGM dated 51222. Previously, owners and operators of the Publisher have been compensated twenty two thousand five hundred dollars by bank wire transfer on 121021 for the distribution of a prior advertisement about BSGM. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 111521 for the distribution of a prior advertisement about BSGM. Previously, owners and operators of the Publisher have been compensated eleven thousand five hundred dollars by bank wire transfer on 11421 for the distribution of a prior advertisement about BSGM. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 62321 for the distribution of a prior advertisement about BSGM. Prior to the past year, at the time of publication, we disclosed our compensation for the distribution of advertisements about BSGM. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.
www.LionStockAlerts.comDisclaimer and www.LionStockAlerts.comPrivacy-Policy
By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.
Our records indicate that . requested and confirmed to be added to LionStockAlerts.com on July 23, 2019.
6020 Bent Pine Drive
Orlando FL 32828
Get Every Penny Stock Alert!
OTC Dynamics tracks all penny stock promotions. Become a member today and never miss another penny stock promotion!
OTC Dynamics is not affiliated with the company being promoted or the associated stock promoter.
The information on this page is not a recommendation to buy or sell securities.